Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Merck
UBS
US Army
US Department of Justice
QuintilesIMS
Fish and Richardson
Chinese Patent Office
Harvard Business School

Generated: April 20, 2018

DrugPatentWatch Database Preview

CAPOZIDE 50/25 Drug Profile

« Back to Dashboard

When do Capozide 50/25 patents expire, and what generic alternatives are available?

Capozide 50/25 is a drug marketed by Apothecon and is included in one NDA.

The generic ingredient in CAPOZIDE 50/25 is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
Summary for CAPOZIDE 50/25
Drug patent expirations by year for CAPOZIDE 50/25

US Patents and Regulatory Information for CAPOZIDE 50/25

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon CAPOZIDE 50/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-003 Oct 12, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CAPOZIDE 50/25

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apothecon CAPOZIDE 50/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-003 Oct 12, 1984 ➤ Sign Up ➤ Sign Up
Apothecon CAPOZIDE 50/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-003 Oct 12, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Chinese Patent Office
Teva
Fish and Richardson
Merck
QuintilesIMS
Baxter
UBS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.